ArticleBMC ophthalmology2024

Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.

Hui Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.